New

Armaron Bio, a Melbourne-based drug development company focused on heart failure and other diseases, is pleased to announce that it has begun its Phase II clinical trial for NP202, its novel…

The U.S. Food and Drug Administration today approved Adynovate, Antihemophilic Factor (Recombinant), PEGylated for use in adults and adolescents, aged 12 years and older, who have Hemophilia A.…

A new 23 million euro initiative to accelerate the search for an effective HIV vaccine begins today.
Financed by the European Commission, the European AIDS Vaccine Initiative (EAVI2020)…

Among patients with proliferative diabetic retinopathy, treatment with an injection in the eye of the drug ranibizumab resulted in visual acuity that was not worse than panretinal photocoagulation…

ADM Tronics Unlimited, Inc. (OTCQB: ADMT) has announced that Angiodroid America, Inc. has withdrawn its Premarket Notification 510(k) application filed with the US Food and Drug Administration (…

In real-world settings, patients with schizophrenia whose symptoms do not respond to standard antipsychotic medications have better outcomes if they are switched to clozapine instead of another…

　　The Yaojiao Hui and after last year‘s forum is the National Federation of Chamber of Commerce and the pharmaceutical industry in Jilin Province successfully held the first session of the…

　　Beijing University of Traditional Chinese Medicine in the production of bulk drug for the main business， by the API periodic overcapacity， national environmental standards to enhance the impact…

US Pacific Northwest National Laboratory PNNL recently developed zinc iodine compound battery fluid. Compared to the grid for new energy storage and next-generation conventional flow batteries,…

　　BIOME Device Boston Boston held， Booth 101， will show highlights American medical grade liquid silicone rubber material， as well as improve the company‘s latest CNC machining with 3D printing…